Disclaimer: Independent educational project. Not affiliated with ZoomRx. Built by Kaushal Khodifad. Data from public sources; figures are estimates.return to portfolio
Disclaimer: Independent educational project. Not affiliated with ZoomRx.

Live Moderator

Pick a respondent persona.

You'll play the oncologist. The AI moderator runs the interview using the 1L EGFR+ NSCLC discussion guide. Your replies are persisted only for this session.

Study

1L EGFR+ NSCLC Treatment Decisions

An AI-moderated In-Depth Interview with a practicing oncologist about first-line EGFR+ NSCLC treatment choices.

Back to PRD

↑ Independent educational project by Kaushal Khodifad. ZoomRx is a real company in the AI-moderated qualitative pharma primary market research space; this design and the underlying prototype were built by Kaushal as a portfolio study. Not affiliated with, endorsed by, or representative of ZoomRx's actual product. Data is from public sources. Figures are estimates.

Return to portfolioOpen the live demo